Adient (NYSE:ADNT) Stock, Quote.Headers.trade-ideas

Adient

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion.

Earnings

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

ADNT

ARCB

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Adient plc (NYSE: ADNT) is an automotive seating supplier. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 60 days.

New Strong Sell Stocks for July 1st

Earnings Beats

Guidance

GELYY

Adient (NYSE: ADNT) reported adjusted earnings per share (ETF:EPS) of 54 cents for the second quarter of fiscal 2024. Earnings rose from 32 cents recorded in the year-ago period and outpaced the Zacks Consensus Estimate of 39 cents.

Adient Q2 Earnings Beat Estimates, Guidance Revised

cars shutter

Equities

Movers

General

Rydex ETF Trust S&P Midcap 400 Pure Value ETF

Adient Plc shares dip post-Q2 earnings, despite beating adjusted EPS but missing sales estimates, as it lowers FY24 outlook.

Why Is Automotive Seating Company Adient Stock Falling After Q2 Earnings?

Adient PLC

B of A Securities analyst John Murphy maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Buy and lowers the price target from $42 to $40.

Price Target

B of A Securities Maintains Buy on Adient, Lowers Price Target to $40

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Neutral and lowers the price target from $32 to $31.

JP Morgan Maintains Neutral on Adient, Lowers Price Target to $31

Adient's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) short percent of float has risen 6.14% since its last report. The company recently reported that it has 5.14 million shares sold short, which is 8.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.02 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Adient Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721151910_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Adient has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Adient's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Adient's peer group average for short interest as a percentage of float is 7.23%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Adient?

Barclays analyst Dan Levy maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Equal-Weight and lowers the price target from $34 to $29.

Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $29

UBS analyst Colin Langan maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Neutral and lowers the price target from $31 to $27.

UBS Maintains Neutral on Adient, Lowers Price Target to $27

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adient plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adnt#NYSE">ADNT</a>) is an automotive seating supplier. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 60 days.
ArcBest Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arcb#NASDAQ">ARCB</a>) is a freight transportation and integrated logistics services company. The Zacks Consensus Estimate for its current year earnings has been revised 15% downward over the last 60 days.
The GEO Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/geo#NYSE">GEO</a>) is a company that owns, leases, and manages secure facilities, processing centers, and reentry centers. The Zacks Consensus Estimate for its current year earnings has been revised 3.8% downward over the last 60 days.
<a href="https://www.zacks.com/stock/news/2295383/new-strong-sell-stocks-for-july-1st?cid=CS-BENZ-FT-tale_of_the_tape|new_zacks_5_rank_stocks-2295383">To read this article on Zacks.com click here.</a>

Exane BNP Paribas analyst James Picariello upgrades Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) from Underperform to Neutral and announces $26 price target.

Upgrades

Exane BNP Paribas Upgrades Adient to Neutral, Announces $26 Price Target

Adient's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) short percent of float has risen 5.8% since its last report. The company recently reported that it has 4.84 million shares sold short, which is 7.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Adient Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719508515_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Adient has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Adient's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Adient's peer group average for short interest as a percentage of float is 7.24%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

In the preceding three months, 8 analysts have released ratings for Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $35.12, with a high estimate of $46.00 and a low estimate of $30.00. A decline of 8.18% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1719324085_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Adient. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$32.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$34.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Emmanuel Rosner</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$30.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$37.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$37.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Adient. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Adient compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Adient's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ADNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Adient analyst ratings.</a>
<h2>Discovering Adient: A Closer Look</h2>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion.
<h3>A Deep Dive into Adient's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Adient's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -4.14%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1.87%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.21%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Adient's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.75%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.22, Adient faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Adient

Wells Fargo analyst Colin Langan maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Overweight and lowers the price target from $33 to $32.

Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $32

WIIM

ALUR

AMST

APTV

DBGI

GDHG

GOEV

GSUN

MBLY

MGOL

MYTE

NWTN

PENN

RERE

THCH

TRNR

TWOU

VLCN

VTRU

ZAPP

Shares of companies within the broader discretionary sector are trading lower following softer-than-expected consumer sentiment data.

Adient (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adnt#NYSE">ADNT</a>) reported adjusted earnings per share (ETF:EPS) of 54 cents for the second quarter of fiscal 2024. Earnings rose from 32 cents recorded in the year-ago period and outpaced the Zacks Consensus Estimate of 39 cents.
The company generated net sales of $3.75 billion, which decreased 4.1% year over year and missed the Zacks Consensus Estimate of $3.83 billion.
<div class="chart_embed">
<h3>Adient Price, Consensus and EPS Surprise</h3>
<a href="https://www.zacks.com/stock/chart/ADNT/price-consensus-eps-surprise-chart?icid=chart-ADNT-price-consensus-eps-surprise-chart"><img alt="Adient Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/ae/1715598026.png" style="height:268px; width:574px" title="" /> </a>
Adient price-consensus-eps-surprise-chart | Adient Quote
</div>
<h3>Segmental Performance</h3>
Adient currently operates through three reportable segments &mdash; Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia). 
In the reported quarter, the Americas segment recorded revenues of $1.66 billion, which declined 5.7% from the year-ago period and missed the Zacks Consensus Estimate of $1.80 billion. The segment recorded an adjusted EBITDA of $80 million, which increased from $72 million recorded in the prior-year quarter and beat the Zacks Consensus Estimate of $75 million, driven by improved business performance and commodity tailwind. 
The EMEA segment registered revenues of $1.37 billion, which declined 2.2% year over year and missed the Zacks Consensus Estimate of $1.38 billion. The segment recorded EBITDA of $57 million, which was higher than the $53 million generated in the year-ago period. It also outpaced the Zacks Consensus Estimate of $53 million on the back of improved business performance and net commodity benefits. 
In the fiscal second quarter, revenues in the Asia segment came in at $742 million, which declined 4.1% year over year and missed the Zacks Consensus Estimate of $774 million. The segment&#39;s adjusted EBITDA fell 0.8% year over year to $112 million due to unfavorable volume and product mix.
<h3>Financial Position</h3>
Adient had cash and cash equivalents of $905 million as of Mar 31, 2024, compared with $1.11 billion as of Sep 30, 2023. 
As of Mar 31, 2024, long-term debt amounted to $2.4 billion. 
Capital expenditures totaled $69 million compared with $56 million in the prior-year quarter. 
During the quarter under review, ADNT repurchased nearly 1.5 million shares for $50 million.
<h3>Revised Guidance 2024</h3>
Adient envisions fiscal 2024 revenues in the range of $14.8-$14.9 billion, down from the previous guidance of $15.40-$15.50 billion. Adjusted EBITDA is estimated in the range of $900-$920 million, down from the prior guidance of $985 million. Equity income is projected to be $80 million, up from the previous guidance of $70 million.
Free cash flow is anticipated to be $250 million, down from the previous guidance of $300 million. Capex and cash tax are estimated between $310 million and $105 million, respectively. The company expects interest expenses to be $185 million.
<h3>Zacks Rank &amp; Key Picks</h3>
ADNT currently carries a Zacks Rank #5 (Strong Sell). 
Some better-ranked players in the auto space are Geely Automobile Holdings Limited (OTC: <a class="ticker" href="https://www.benzinga.com/stock/gelyy#OTC">GELYY</a>) and Oshkosh Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/osk#NYSE">OSK</a>), each sporting a Zacks Rank #1 (Strong Buy) at present. 
The Zacks Consensus Estimate for GELYY&#39;s 2024 sales suggests year-over-year growth of 36.6%. The EPS estimates for 2024 and 2025 have moved up 34 cents and 54 cents, respectively, in the past 60 days. 
The Zacks Consensus Estimate for OSK&#39;s 2024 sales and earnings suggests year-over-year growth of 9.86% and 10.72%, respectively. The EPS estimates for 2024 and 2025 have improved 73 cents and 70 cents, respectively, in the past 30 days.
<a href="https://www.zacks.com/stock/news/2272607/adient-adnt-q2-earnings-beat-estimates-guidance-revised?cid=CS-BENZ-FT-analyst_blog|earnings_article-2272607">To read this article on Zacks.com click here.</a>

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Underweight and lowers the price target from $35 to $32.

Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $32

Barclays analyst Dan Levy maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Equal-Weight and lowers the price target from $37 to $34.

Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $34

Deutsche Bank analyst Emmanuel Rosner maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Hold and lowers the price target from $32 to $30.

Deutsche Bank Maintains Hold on Adient, Lowers Price Target to $30

Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.83, a high estimate of $46.00, and a low estimate of $33.00. A 7.17% drop is evident in the current average compared to the previous average price target of $41.83. 
<img src="https://www.benzinga.com/files/images/story/2024/1715011229_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Adient by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$37.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$37.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$40.00</td>
<td>$41.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Adient. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Adient compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Adient's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Adient's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ADNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Adient analyst ratings.</a>
<h2>All You Need to Know About Adient</h2>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion.
<h3>Understanding the Numbers: Adient's Finances</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Adient's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -1.05% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.55%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Adient's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.89%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Adient's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 1.11, Adient faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

6 Analysts Have This To Say About Adient

Wells Fargo analyst Colin Langan maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Overweight and lowers the price target from $38 to $33.

Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $33

Adient Plc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) shares are&nbsp;<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading lower on Friday.</a>
The firm reported&nbsp;second-quarter&nbsp;adjusted earnings per share of 54 cents,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/n38609036/adient-reports-strong-q2-financial-results-provides-update-to-fy24-outlook" rel="noreferrer noopener">beating&nbsp;the street view&nbsp;of&nbsp;42 cents</a>.
Quarterly sales of $3.750 billion missed the analyst consensus of $3.787 billion. Sales fell over 4%&nbsp;year over year, owing&nbsp;to&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">low volumes and FX headwinds.</a>
The company reported adjusted EBITDA of&nbsp;$227 million, up&nbsp;$12 million&nbsp;year over year. Adjusted EBITDA margin expanded by 60 basis points to 6.1%.
Margins increased&nbsp;on the back of&nbsp;freight efficiencies and lower engineering and administrative&nbsp;spend.
Gross and net debt totaled $2.5 billion and $1.6 billion, respectively, as of March 31. The company exited the quarter with cash and equivalents of $905 million.
Adient&nbsp;announced restructuring charges worth $125 million in the quarter. The company sees $60 million in reduced annual operating costs from this activity, of which 80% will result in net savings. The full benefits are expected by 2027.
Adient lowers FY24 sales outlook to $14.8 billion-$14.9 billion from $15.4 billion-$15.5 billion&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(Estimate: $15.47 billion).</a>&nbsp;The company sees adjusted EBITDA of $900 million-$920 million from the prior ~$985 million.
The outlook&nbsp;is lowered, recognizing&nbsp;slow&nbsp;ramp of launches, adverse customer mix, and softer electric vehicle production in the Americas and&nbsp;EMEA.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, ADNT stock has lost over 19% in the past year. Investors can gain exposure to the stock via&nbsp;Invesco S&amp;P Midcap 400 Pure Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RFV#NYSE">RFV</a>).
Price Action: ADNT shares are trading lower by 8.3% to $27.74 at last check Friday.
Photo via Shutterstock

Adient shares are trading lower after the company reported Q2 financial results and cut its FY24 revenue guidance.

U.S. stock futures were higher this morning, with the Dow futures gaining over 250 points on Friday.
Shares of Stem, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) shares fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results and <a href="https://www.benzinga.com/quote/STEM/earnings">cut its FY24 revenue guidance</a>.
Stem posted a quarterly loss of 46 cents per share, versus market expectations for a loss of 21 cents per share. The company's quarterly sales came in at $25.47 million missing estimates of $57.11 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Stem shares dipped 18.7% to $1.55 in pre-market trading in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Sprout Social, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) shares declined 25.2% to $36.00 in pre-market trading after the company reported worse-than-expected first-quarter revenue results.</li>
<li>Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) fell 14% to $76.50 pre-market trading after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Trupanion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) shares declined 13% to $20.68 in pre-market trading following first-quarter results.</li>
<li>Adient plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) dipped 12.3% to $26.51 in pre-market trading after the company posted second-quarter results and lowered its FY24 outlook.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) shares fell 12.1% to $1.52 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) shares declined 10.1% to $121.92 in pre-market trading after the company lowered its full-year guidance.</li>
<li>Open Text Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTEX#NASDAQ">OTEX</a>) shares fell 9.8% to $32.00 in pre-market trading following third-quarter results. BMO Capital downgraded the stock from Outperform to Market Perform and lowered its price target from $50 to $38.</li>
<li>Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) fell 8.3% to $59.81 pre-market trading after the company reported its first-quarter financial results.</li>
<li>Custom Truck One Source, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) fell 7.5% to $4.5304 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY24 revenue outlook.</li>
<li>Cryoport, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) fell 6.7% to $16.00 in pre-market trading. B. Riley Securities analyst Yuan Zhi downgraded CryoPort from Buy to Neutral and lowered the price target from $22 to $19.</li>
<li>Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) fell 6.4% to $38.57 in pre-market trading following weak first-quarter earnings.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) declined 4.4% to $218.80 in pre-market trading following first-quarter earnings.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/05/38606493/apple-hershey-and-3-stocks-to-watch-heading-into-friday">Apple, Hershey And 3 Stocks To Watch Heading Into Friday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage</a> here

Pre-Market Outlook

BBAI

COIN

CTOS

CYRX

EXPE

FTNT

OTEX

STEM

TRUP

Stem Reports Downbeat Results, Joins Sprout Social, Cloudflare And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Adient plc 2024 Q2 - Results - Earnings Call Presentation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Adient (NYSE:<a href="https://investorplace.com/stock-quotes/adnt-stock-quote/">ADNT</a>) just reported results for the second quarter of 2024.<ul><li>Adient reported earnings per share of 54 cents. This was above the analyst estimate for EPS of 42 cents.</li><li>The company reported revenue of $3.75 billion.</li><li>This was 1.06% worse than the analyst estimate for revenue of $3.79 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/adnt-stock-earnings-adient-for-q2-of-2024/">ADNT Stock Earnings: Adient Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ADNT Stock Earnings: Adient Beats EPS, Misses Revenue for Q2 2024

Adient plc (ADNT) Q2 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Consumer Cyclical sector as 3 analysts just weighed in on Adient (ADNT – Research Report), Churchill Do...

Analysts' Top Consumer Cyclical Picks: Adient (ADNT), Churchill Downs (CHDN)

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Adient (ADNT – Research Report), Alibaba (BABA – Research ...

Analysts' Opinions Are Mixed on These Consumer Cyclical Stocks: Adient (ADNT), Alibaba (BABA) and Booking Holdings (BKNG)

There's a lot to be optimistic about in the Consumer Cyclical sector as 3 analysts just weighed in on Madison Square Garden Entertainment Corp. (MS...

Analysts Are Bullish on Top Consumer Cyclical Stocks: Madison Square Garden Entertainment Corp. (MSGE), Ralph Lauren (RL)

Adient: Consider Financial Prospects And Buyback Yield

In a report released today, Colin Langan from Wells Fargo assigned a Buy rating to Adient (ADNT – Research Report), with a price target of $32.00. ...

Adient (ADNT) Receives a Buy from Wells Fargo

Barclays analyst Dan Levy maintained a Hold rating on Adient (ADNT – Research Report) today and set a price target of $29.00. The company's shares ...

Barclays Reaffirms Their Hold Rating on Adient (ADNT)

Bank of America Securities analyst John Murphy maintained a Buy rating on Adient (ADNT – Research Report) today. The company's shares opened today ...

Bank of America Securities Remains a Buy on Adient (ADNT)

BABA

BKNG

CHDN

MSGE

Press Releases

Adient announces preliminary Q1 fiscal 2024 results

Commodities

Adient releases 2023 Sustainability Report

Adient reports Q1 financial results; reaffirms FY24 outlook

Adient will participate at the Wolfe Research Global Auto and Auto Tech Conference

Mike Heifler joins Adient as vice president of Investor Relations and Strategy

Adient will participate in the Bank of America Global Auto Summit

Adient to discuss Q2 fiscal 2024 financial results on May 3, 2024

Adient reports strong Q2 financial results; provides update to FY24 outlook

Adient to discuss Q3 fiscal 2024 financial results on August 6, 2024

Autoliv

Aptiv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Dana

Dorman Prods

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Hldg

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Adient

Adient (ADNT) Forecast

Adient (NYSE:ADNT) Stock, Quote.Headers.trade-ideas